Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity

Published:2017-08-31 Issue:17 Volume:23 Page:4959-4969
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Anagnostou Valsamo,Yarchoan Mark,Hansen Aaron R.,Wang Hao,Verde Franco,Sharon Elad,Collyar Deborah,Chow Laura Q.M.,Forde Patrick M.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapies;Frontiers in Immunology;2024-08-21

2. A phase 2 study of spartalizumab (PDR001) among patients with recurrent or metastatic esophageal squamous cell carcinoma (KCSG HN18-17, K-MASTER project 12);OncoImmunology;2024-06-24

3. Unlocking the Next Frontier in Precision Oncology: Addressing Drug-Tolerant Residual Disease;Cancer Discovery;2024-06-03

4. Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials;Nature Reviews Clinical Oncology;2024-04-10

5. Segmentation of patients with small cell lung cancer into responders and non-responders using the optimal cross-validation technique;BMC Medical Research Methodology;2024-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP